Skip to main content
Log in

Activities of Clotting, Fibrinolytic, and Anticoagulant Components of Plasma Hemostasis in Patients with Degenerative Diseases of Large Joints

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Analysis of plasma hemostasis parameters was carried out in 110 patients with degenerative diseases of hip or knee joints hospitalized for initial endoprosthetics. Molecular markers of clotting and fibrinolysis and physiological anticoagulants were studied. Activities of all components of plasma hemostasis were normal in 29.4% patients. In 54.1% patients, high clotting activity was compensated for by adequate fibrinolysis activity. High thrombin formation was compensated for by high consumption of physiological anticoagulants in 10.1% patients. In 6.4% patients, high clotting activity was not paralleled by high fibrinolytic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A. A. Baeshko, A. G. Kryuchok, V. A. Yushkevich, et al., Khirurgiya, No. 2, 45–49 (2000).

  2. D. M. Zubairov, Molecular Bases of Blood Clotting and Clot Formation [in Russian], Kazan (2000).

  3. I. I. Kuz’min, S. K. Dubov, P. M. Kondratovskii, et al., Thromboembolic and Hemorrhagic Complications of the Hip Joint Endoprosthetics [in Russian], Vladivostok (2006).

  4. A. P. Momot, Philosophy and Algorithms of Clinical Laboratory Diagnosis of Hemostasis Disorders [in Russian], Barnaul (2004).

  5. C. W. Colwell, Orthopedics, 32, No. 12, Suppl., 67–73 (2009).

    Article  PubMed  Google Scholar 

  6. S. Craven, L. Dewar, X. Yang, et al., Blood Coagul. Fibrinolysis, 18, No. 3, 219–225 (2007).

    Article  PubMed  Google Scholar 

  7. Y. K. Kagoma, M. A. Crowther, J. Douketis, et al., Thromb. Res., 123, No. 5, 687–696 (2009).

    Article  PubMed  CAS  Google Scholar 

  8. D. M. Monroe and M. Hoffman, Arterioscler. Thromb. Vasc. Biol., 26, No. 1, 41–48 (2006).

    Article  PubMed  CAS  Google Scholar 

  9. O. Reikeras and T. Clementsen, J. Thromb. Thrombolysis, 28, No. 4, 425–428 (2009).

    Article  PubMed  Google Scholar 

  10. B. Sokolowska, W. Piecuch, A. Walter-Croneck, et al., Przegl. Lek., 59, No. 7, 502–508 (2002).

    PubMed  Google Scholar 

  11. A. W. Tsai, M. Cushman, W. D. Rosamond, et al., Am. J. Med., 113, No. 8, 636–642 (2002).

    Article  PubMed  Google Scholar 

  12. H. Wada, T. Kobayashi, Y. Abe, et al., J. Thromb. Haemost., 4, No. 6, 1253–1258 (2006).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. P. Antropova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 153, No. 4, pp. 495-498, April, 2012

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antropova, I.P., Yushkov, B.G. Activities of Clotting, Fibrinolytic, and Anticoagulant Components of Plasma Hemostasis in Patients with Degenerative Diseases of Large Joints. Bull Exp Biol Med 153, 505–507 (2012). https://doi.org/10.1007/s10517-012-1752-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-012-1752-2

Key Words

Navigation